Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations

4 October 2002

journal article
review article
Published by Wiley in Acta Psychiatrica Scandinavica

Vol. 106 (5) , 323-330
https://doi.org/10.1034/j.1600-0447.2002.01331.x

Abstract

Objective: To review the literature on efficacy and risks of combining antipsychotics (atypical with atypical or conventional) and suggest a rationale and strategies for future clinical trials. Meth...

Keywords

This publication has 46 references indexed in Scilit:

Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder
American Journal of Psychiatry, 2002
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
American Journal of Psychiatry, 2001
Clozapine and risperidone: combination/ augmentation treatment of refractory schizophrenia: a preliminary observation
Acta Psychiatrica Scandinavica, 2000
Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret?
The Journal of Clinical Psychiatry, 1999
Mortality in schizophrenia
The British Journal of Psychiatry, 1998
Evaluation of Treatment-Resistant Schizophrenia
Schizophrenia Bulletin, 1997
The Genetics of Personality Disorder
The British Journal of Psychiatry, 1992
Clozapine in China: a review and preview of US/PRC collaboration
Psychopharmacology, 1989
Determining Optimal Therapy — Randomized Trials in Individual Patients
New England Journal of Medicine, 1986
The long-term course of the schizophrenic psychoses
Psychological Medicine, 1974